Interest in novel RGD peptides has been increasingly growing as the interactions between RGD peptides and integrins are the basis for a variety of cellular functions and medical applications such as modulation of cell adhesion, invasion, tumor angiogenesis, and metastasis. In particular, we have been interested in novel NIR fluorescent RGD peptides as potential optical contrast agents for in vivo tumor optical imaging. Therefore, two cyclic RGD penta-peptides conjugated with a NIR fluorescent carbocyanine (Cypate), i.e. lactam-based cyclo[RGDdK(Cypate)] (1) and disulfide-containing Cypate-cyclo(CRGBC)-NH2 (2), were designed and synthesized. The competitive binding assay between the purified αvβ 3 integrin and the peptide ligands using 125I-echistatin as a tracer showed that 1 had a higher receptor binding affinity (IC 50∼10-7 M) than 2 (1C50∼10-6 M). Furthermore, the internalization of l in A549 cells in vitro was less than 2, as revealed by fluorescence microscopy. These results suggest that both the lactam- and disulfide-based cyclic RGB penta-peptides should be further studied structurally and functionally to elucidate the advantages of each class of compounds.